Search research articles
Contact Us
Filters
Showing results (91-100 of 118) with videos related to
Page
of 12
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Roberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
The American Journal of Surgical Pathology
|
October 23, 2013
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists
Vijayalakshmi Ananthanarayanan, Yi Pan, Maria Tretiakova, et al.
Science Translational Medicine
|
April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Research Square
|
November 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Journal of the National Cancer Institute
|
February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study
Kyle M Rose, Rachel Pham, Niki M Zacharias, et al.
Nature Communications
|
February 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Clinical Genitourinary Cancer
|
October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma
Pavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Cancers
|
December 10, 2021
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Daniel D Shapiro, Melinda Soeung, Luigi Perelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 118) with videos related to
Sort By:
Page
of 12
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Roberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
The American Journal of Surgical Pathology
|
October 23, 2013
Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists
Vijayalakshmi Ananthanarayanan, Yi Pan, Maria Tretiakova, et al.
Science Translational Medicine
|
April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Research Square
|
November 28, 2024
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Journal of the National Cancer Institute
|
February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study
Kyle M Rose, Rachel Pham, Niki M Zacharias, et al.
Nature Communications
|
February 21, 2025
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Clinical Genitourinary Cancer
|
October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma
Pavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Cancers
|
December 10, 2021
Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies
Daniel D Shapiro, Melinda Soeung, Luigi Perelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma
Kai Yu, Rebecca S Tidwell, Tharakeswara K Bathala, et al.
Page
of 12